EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
EVFM
Delisted
EVFM was delisted on the 10th of August, 2022.
103 hedge funds and large institutions have $74.5M invested in Evofem Biosciences, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 31 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
14% less call options, than puts
Call options by funds: $1.05M | Put options by funds: $1.22M
Holders
103
Holding in Top 10
–
Calls
$1.05M
Puts
$1.22M
Top Buyers
| 1 | +$4.83M | |
| 2 | +$4.09M | |
| 3 | +$4M | |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$2.97M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$994K |
Top Sellers
| 1 | -$5.96M | |
| 2 | -$362K | |
| 3 | -$239K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$232K |
| 5 |
AC
Aristides Capital
Louisville,
Kentucky
|
-$222K |